nach oben

memo - Magazine of European Medical Oncology

Inhalt (13 Artikel)

Welcome to the new associate Editor-in-Chief of memo

editorial

Wolfgang Hilbe, Waltraud Radlherr

A welcome statement from the associate Editor-in-Chief

editorial

Rupert Bartsch

ASH 2015—insights and outlooks

editorial

Niklas Zojer

Rationale of an economically driven PD1 biomarker development in lung cancer—an academic dilemma

editorial

Wolfgang Hilbe, Rupert Bartsch, Christoph Zielinski

Novel strategies in the management of chronic lymphocytic leukemia (CLL)

special report

Daniel Heintel

Acute myeloid leukemia: highlights from ASH 2015

short review

Michael Pfeilstöcker

Indolent lymphoma at ASH 2015: new treatment approaches

short review

Thomas Nösslinger

Practice changing information in aggressive lymphoma, ASH 2015

short review

Michael A. Fridrik

Focus on multiple myeloma at ASH 2015

short review

Niklas Zojer

Reversal of direct oral anticoagulants in hemophilia treatment

Open Access
short review

Clemens Feistritzer, Stefan Schmidt

ASH 2015 – stem cell transplantation

short review

Johannes Clausen

Antiangiogenic therapies in ovarian cancer

Open Access
short review

Alexander Reinthaller

Healthcare resource utilization and G‑CSF use in patients with solid tumors or hematological malignancies hospitalized for febrile neutropenia in Bulgaria, Czech Republic and Slovakia

original report

Georgi Mihaylov, Zhasmina Mihaylova, Lubos Drgona, Andrea Cipkova, Jan Novak, Roumyana Petrova

Jul 16

Ausgabe: Sonderheft 3/2016

Report from the ASCO 2016 Congress, Chicago, 3rd-7th June, 2016

Dez 16

Ausgabe: 4/2016

Aktuelle Ausgaben

memo - Magazine of European Medical Oncology 1/2025
memo - Magazine of European Medical Oncology 4/2025
JAK2 Mutations in Polycythemia Vera: From Molecular Origins to Inflammatory Pathways and Clinical Implications
memo - Magazine of European Medical Oncology 5/2024
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES Report from the American Society of Hematology (ASH) Annual Meeting, December 7–10, 2024
memo - Magazine of European Medical Oncology 4/2024
memo - Magazine of European Medical Oncology 3/2024
A GLOBAL CONGRESS DIGEST ON LUNG CANCER Report from the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer, September 7th –10th , hybrid congress
memo - Magazine of European Medical Oncology 3/2024
memo - Magazine of European Medical Oncology 2/2024
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES Report from the European Hematology Association (EHA) 2024 Congress (hybrid), 13th – 16th June 2024
memo - Magazine of European Medical Oncology 2/2024
memo - Magazine of European Medical Oncology 1/2024
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology
memo - Magazine of European Medical Oncology 1/2024

Scrollen für mehr

Benutzen Sie die Pfeiltasten für mehr

Scrollen oder Pfeiltasten für mehr

Springer Medizin Österreich

memo - Magazine of European Medical Oncology

Ausgabe 3/2016

Inhalt (13 Artikel)

Welcome to the new associate Editor-in-Chief of memo

A welcome statement from the associate Editor-in-Chief

ASH 2015—insights and outlooks

Rationale of an economically driven PD1 biomarker development in lung cancer—an academic dilemma

Novel strategies in the management of chronic lymphocytic leukemia (CLL)

Acute myeloid leukemia: highlights from ASH 2015

Indolent lymphoma at ASH 2015: new treatment approaches

Practice changing information in aggressive lymphoma, ASH 2015

Focus on multiple myeloma at ASH 2015

Reversal of direct oral anticoagulants in hemophilia treatment

ASH 2015 – stem cell transplantation

Antiangiogenic therapies in ovarian cancer

Healthcare resource utilization and G‑CSF use in patients with solid tumors or hematological malignancies hospitalized for febrile neutropenia in Bulgaria, Czech Republic and Slovakia

Aktuelle Ausgaben

memo - Magazine of European Medical Oncology 1/2025

JAK2 Mutations in Polycythemia Vera: From Molecular Origins to Inflammatory Pathways and Clinical Implications

A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES Report from the American Society of Hematology (ASH) Annual Meeting, December 7–10, 2024

memo - Magazine of European Medical Oncology 4/2024

A GLOBAL CONGRESS DIGEST ON LUNG CANCER Report from the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer, September 7th –10th , hybrid congress

memo - Magazine of European Medical Oncology 3/2024

A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES Report from the European Hematology Association (EHA) 2024 Congress (hybrid), 13th – 16th June 2024

memo - Magazine of European Medical Oncology 2/2024

Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology

memo - Magazine of European Medical Oncology 1/2024